Search - tctmd.com

Displaying 401 - 415 of 415

Sort: Relevancy | Date

News Daily News

El Celecoxib Aumenta la Eficacia de los SLF a un determinado Coste Clínico

March 15, 2012

News Daily News

Celecoxib Enhances DES Efficacy, But at Clinical Cost

March 15, 2012

News Daily News

Study Compares Bypass, Angioplasty for SFA Disease

Caitlin E. Cox

March 07, 2012

News Daily News

Estudio compara Bypass y Angioplastia contra la Enfermedad de la AFS

Caitlin E. Cox

March 07, 2012

News Daily News

Stent Thrombosis Risk Lower with Xience vs. First-Generation DES

Yael L. Maxwell

March 06, 2012

News Daily News

El Riesgo de Trombosis del Stent es Menor con Xience que con SLF de 1ª Generación

Yael L. Maxwell

March 06, 2012

News Daily News

Un Estudio Insta a tener un Valor de Corte Más Alto para la Elevación de Troponina en el Diagnóstico del IM

Caitlin E. Cox

March 05, 2012

News Daily News

Study Urges Higher Cutoff for Troponin Elevation in Diagnosing MI

Caitlin E. Cox

March 05, 2012

News Daily News

Live Case Procedures Just as Safe as in Daily Practice

Caitlin E. Cox

February 21, 2012

News Daily News

Complications of In-Stent Restenosis High, Traditional Risk Factors Absent

Yael L. Maxwell

February 15, 2012

News Daily News

Meta-Analysis Shows Increased Risk of MI, ACS with Dabigatran

L.A. McKeown

January 09, 2012

News Daily News

FFR-Guidance Demonstrates Benefits in Patients with Unstable Angina, NSTEMI

L.A. McKeown

December 08, 2011

News Daily News

Studies Support Staged PCI for STEMI Patients with Multivessel Disease

August 01, 2011

News Daily News

Cerebral Atherosclerosis Predicts Post-CABG Stroke Risk

April 25, 2011

News Daily News

Paclitaxel-Eluting Balloon Effective for DES Restenosis

February 22, 2011

Advertisement

El Celecoxib Aumenta la Eficacia de los SLF a un determinado Coste Clínico

Celecoxib Enhances DES Efficacy, But at Clinical Cost

Study Compares Bypass, Angioplasty for SFA Disease

Estudio compara Bypass y Angioplastia contra la Enfermedad de la AFS

Stent Thrombosis Risk Lower with Xience vs. First-Generation DES

El Riesgo de Trombosis del Stent es Menor con Xience que con SLF de 1ª Generación

Un Estudio Insta a tener un Valor de Corte Más Alto para la Elevación de Troponina en el Diagnóstico del IM

Study Urges Higher Cutoff for Troponin Elevation in Diagnosing MI

Live Case Procedures Just as Safe as in Daily Practice

Complications of In-Stent Restenosis High, Traditional Risk Factors Absent

Meta-Analysis Shows Increased Risk of MI, ACS with Dabigatran

FFR-Guidance Demonstrates Benefits in Patients with Unstable Angina, NSTEMI

Studies Support Staged PCI for STEMI Patients with Multivessel Disease

Cerebral Atherosclerosis Predicts Post-CABG Stroke Risk

Paclitaxel-Eluting Balloon Effective for DES Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content